Involvement of the Wnt-β-catenin pathway in invasion and migration of oral squamous carcinoma cells

International Journal of Oncology

Volumn 37, Issue 5, 2010, Pages 1095-1103

  Iwai, Soichi ^a   Yonekawa, Atsuko ^a   Harada, Chie ^a   Hamada, Masakazu ^a   Katagiri, Wataru ^b   Nakazawa, Mituhiro ^a   Yura, Yoshiaki ^a  

^a OSAKA UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell invasion and migration; Cytoplasmic accumulation; Epithelial mesenchymal transition; Oral squamous cell carcinoma; catenin

Indexed keywords

BETA CATENIN; COMPLEMENTARY DNA; GLYCOGEN SYNTHASE KINASE 3BETA; LYMPHOID ENHANCER FACTOR 1; MATRILYSIN; PROTEIN CDC42; RAC PROTEIN; RHO FACTOR; T CELL FACTOR PROTEIN; UVOMORULIN; WNT PROTEIN;

ACTIN FILAMENT; ARTICLE; CARCINOGENESIS; CELL INTERACTION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SQUAMOUS CELL CARCINOMA;

EID: 77957862980     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000761     Document Type: Article

References (37)

1. Veeman MT, Axeirod JD and Moon RT: A second canonical Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev Cell 5: 367-377, 2003.
2. Nelson WJ and Nusse R: Convergence of Wnt, beta-catenin and cadherin pathways. Science 303: 1483-1487, 2004.
3. Kikuchi A: Roles of Axin in the Wnt signaling pathway. Cell Signal 11: 777-788, 1999. (Pubitemid 29507486)
4. Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, Zhang Z, Lin X and He X: Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108: 837-847, 2002. (Pubitemid 34327534)
5. Kitagawa S, Hatakeyama S, Shirane M, Matsumoto M, Ishida N, Hattori K, Nakamichi I, Kikuchi A, Nakayama KI and Nakayama K: An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of β-catenin. EMBO J 18: 2401-2410, 1999. (Pubitemid 29213274)
6. Polakis P: Wnt signaling and cancer. Genes Dev 14: 1837-1851, 2000.
7. Huristone A and Clevers H: T-cell factors: turn-ons and turnoffs. EMBO J 21: 2303-2311, 2002.
8. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, Da Costa LT, Morin PJ, Vogelstein B and Kinzler KW: Identification of c-myc as a target of the APC pathway. Science 281: 1509-1512, 1998.
9. Tetsu O and McCormick F: Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422-426, 1999.
10. Mann B, Gelos M, Siedow A, Hanski ML, Gratchev A, Ilyas M, Bodmer WF, Moyer MP, Riecken EO, Buhr HJ and Hanski C: Target genes of beta-catenin-T cell factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci USA 96: 1603-1608, 1999. (Pubitemid 29098498)
11. Takahashi M, Tsunoda T, Seiki M, Nakamura Y and Furukawa Y: Identification of membrane-type matrix metalloproteinase-1 as a target of the β-catenin/Tcf4 complex in human colorectal cancers. Oncogene 21: 5861-5867, 2002. (Pubitemid 35007236)
12. Brabletz T, Jung A, Dag S, Hlubek F and Kirchner T: β-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 155: 1033-1038, 1999. (Pubitemid 29488909)
13. Morin PJ, Sparks AB, Korinck V, Barker N, Clevers H, Vogelstein B and Kinzler KW: Activation of beta-catenin-Tcf signaling in colon cancer by mutation in beta-catenin or APC. Science 275: 1787-1790, 1997. (Pubitemid 27136715)
14. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E and Polakis P: Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 275: 1790-1792, 1997. (Pubitemid 27136716)
15. Lo Muzio L, Staibano S, Pannone G, Grieco M, Mignogna MD, Cerrato A, Testa MF and De Rosa G: Beta- and gamma-catenin expression in oral squamous cell carcinomas. Anticancer Res 19: 3817-3826, 1999.
16. Gao S, Eiberg H, Krogdahl A, Liu CJ and Sorensen JA: Cytoplasmic expression of E-cadherin and beta-catenin correlated with LOH and hypermethylation of the APC gene in oral squamous cell carcinomas. J Oral Pathol Med 34: 116-119, 2005.
17. Iwai S, Katagiri W, Kong C, Amekawa S, Nakazawa M and Yura Y: Mutation of the APC, beta-catenin, and axin1 genes and cytoplasmic accumulation of beta-catenin in oral squamous cell carcinoma. J Cancer Res Clin Oncol 15: 1-10, 2005. (Pubitemid 41630700)
18. Schmalhofer O, Brabletz S and Brabletz T: E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 28: 151-166, 2009.
19. Lopes FF, Da Costa Miguel MC, Pereira AL, Da Cruz MC, De Almeida Freitas R, Pinto LP and De Souza LB: Changes in immunoexpression of E-cadherin and beta-catenin in oral squamous cell carcinoma with and without nodal metastasis. Ann Diagn Pathol 13: 22-29, 2009.
20. Prasad CP, Mirza S, Sharma G, Prashad R, DattaGupta S, Rath G and Ralhan R: Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast. Life Sci 83: 318-325, 2008.
21. Tanaka N, Odajima T, Ogi K, Ikeda T and Satoh M: Expression of E-cadherin, alpha-catenin and beta-catenin in the process of lymph node metastasis in oral squamous cell carcinoma. Br J Cancer 89: 557-563, 2003. (Pubitemid 37026443)
22. Kurtz KA, Hoffman HT, Zimmerman MB and Robinson RA: Decreased E-cadherin but not beta-catenin expression is associated with vascular invasion and decreased survival in head and neck squamous carcinomas. Otolaryngol Head Neck Surg 134: 142-146, 2006.
23. Horikoshi M, Kinura Y, Nagura H, Ono T and Ito H: A new human cell line derived from human carcinoma of the gingival. Jpn J Oral Maxillofac Surg 20: 100-106, 1974.
24. Nagasawa Y, Miyoshi Y, Iwao K, Shinomura Y, Matsuzawa Y and Nakamura Y: Transformation and morphological changes of murine L cells by transfection with a mutated form of beta-catenin. Cancer Res 59: 3539-3542, 1999. (Pubitemid 29381847)
25. Kemler R: From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet 9: 317-322, 1993.
26. Jaffe A and Hall A: Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 21: 247-269, 2005.
27. Price LS and Collard JG: Regulation of the cytoskeleton by Rho-family GTPases: implications for tumor cell invasion. Semin Cancer Biol 11: 167-173, 2001.
28. Giles RH, van Es JH and Clevers H: Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653: 1-24, 2003.
29. Yang F, Zeng Q, Yu G, Li S and Wang CY: Wnt/β-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC. Cell Signal 18: 679-687, 2005. (Pubitemid 43113298)
30. Miwa N, Furuse M, Tsukita S, Niikawa N, Nakamura Y and Furukawa Y: Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers. Oncol Res 12: 469-476, 2001. (Pubitemid 33791807)
31. Thiery JP, Acloque H, Huang RY and Nieto MA: Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890, 2009.
32. Xue C, Plieth D, Venkov C, Xu C and Neilson EG: The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res 63: 3386-3394, 2003. (Pubitemid 36735899)
33. Peinado H, Portillo F and Cano A: Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol 48: 365-375, 2004. (Pubitemid 39360388)
34. Fukata M, Nakagawa M and Kaibuchi K: Roles of Rho-family GTPases in cell polarisation and directional migration. Curr Opin Cell Biol 15: 590-597, 2003. (Pubitemid 37176968)
35. Asnaghi L, Vass WC, Quadri R, Day PM, Qian X, Braverman R, Papageorge AG and Lowy DR: E-cadherin negatively regulates neoplastic growth in non-small cell lung cancer: role of Rho GTPases. Oncogene 15: 1-12, 2010.
36. Takahashi-Yanaga F and Sasaguri T: Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: inhibitors of the Wnt/beta-catenin signaling pathway as novel anticancer drugs. J Pharmacol Sci 109: 179-183, 2009.
37. Choi H, Gwak J, Cho M, Ryu MJ, Lee JH, Kim SK, Kim YH, Lee GW, Yun MY, Cuong NM, Shin JG, Song GY and Oh S: Murrayafoline A attenuates the Wnt/beta-catenin pathway by promoting the degradation of intracellular beta-catenin proteins. Biochem Biophys Res Commun 391: 915-920, 2010.